Bio-Rad Laboratories, Inc. Class B(BIO.B)
$367.98-10.52 (-2.78%)
BIO.B
Bio-Rad Laboratories, Inc. Class B earnings date
$367.98
At close:-10.52 (-2.78%)
Want to see BIO.B full AI Analyst Report?
Bio-Rad Laboratories, Inc. Class B (BIO.B) Q2 2026 Earnings Report
1 Followers
BIO.B Q2 2026 EPS Results
- Actual EPS
- $2.62
- Consensus EPS
- $1.78
- Beat/Miss
- Beat by +$0.84
- One Year Ago EPS
- $2.61
BIO.B Q2 2026 Revenue Results
- Actual Revenue
- $651.00M
- Expected Revenue
- $624.80M
- Beat/Miss
- Beat by +$26.20M
- YoY Revenue Growth
- -0.09%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/04/2026
- Time
- After Close
- Conference Call
- Tuesday, August 4, 2026
BIO.B Upcoming Earnings
Bio-Rad Laboratories, Inc. Class B's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
BIO.B Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
BIO.B Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 2.83- | 2.51 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 2.232.65 | 2.26 | 17.26% (+0.39) | |
| Aug 04, 2026 | 2026 (Q2) | 1.782.62 | 2.61 | 0.38% (+0.01) | |
| Apr 30, 2026 | 2026 (Q1) | 2.011.89 | 2.54 | -25.59% (-0.65) | |
| Feb 12, 2026 | 2025 (Q4) | 2.692.51 | 2.9 | -13.45% (-0.39) | |
| Oct 29, 2025 | 2025 (Q3) | 1.892.26 | 2.01 | 12.44% (+0.25) | |
| Jul 31, 2025 | 2025 (Q2) | 1.752.61 | 3.11 | -16.08% (-0.50) | |
| May 01, 2025 | 2025 (Q1) | 1.822.54 | 2.29 | 10.92% (+0.25) | |
| Feb 13, 2025 | 2024 (Q4) | 2.862.90 | 3.1 | -6.45% (-0.20) | |
| Oct 30, 2024 | 2024 (Q3) | 1.132.01 | 2.33 | -13.73% (-0.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
